(Total Views: 361)
Posted On: 05/20/2021 10:04:15 AM
Post# of 145875
With the safety record of Leronlimab...there is NO reason...if we are shaping the trial that the FDA should have objected to 4 DOSES...knowing the results at 7-14-21-28 days...You would have to be totally deranged... NOT to see the efficacy points and how the EXTRA Molecule would have seen greatly improved results...WE wanted 4...They wanted 2...simply the FACTS.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)